- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03910764
Surveillance Study of Candiduria in Hospitalized Patients
October 5, 2020 updated by: Chen Ying-Chun, Taichung Veterans General Hospital
Retrospective Surveillance Study of Candiduria in Hospitalized Patients
The purpose of the study is to explore the epidemiology, underlying diseases, indwelling catheter duration, laboratory data, diagnosis, treatment and prognosis of patients with Candiduria.
Study Overview
Detailed Description
The study is a retrospective study.
Investigators will review medical records of patients with Candiduria from January 2015 to December 2017 to collect data about personal data, underlying diseases, indwelling catheter duration, laboratory data of urine routines and urine cultures, the symptom of fever, diagnosis, treatment and prognosis.
After the data collection, investigators will run a descriptive statistics to find out the profile of the medical care of Candiduria in Taiwan.
Study Type
Observational
Enrollment (Actual)
536
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Taichung, Taiwan, 40705
- Taichung Veterans General Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
all patients with Candiduria
Description
Inclusion Criteria:
- patients with Candiduria
Exclusion Criteria:
- patients without Candiduria
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
prevalence rate of Candiduria
Time Frame: January 2015 to December 2017
|
the number of patients with Candiduria/ the number of all hospitalized patients
|
January 2015 to December 2017
|
morbidity rate of underlying diseases
Time Frame: January 2015 to December 2017
|
the proportion of patients with every specific underlying disease
|
January 2015 to December 2017
|
indwelling catheter rate
Time Frame: January 2015 to December 2017
|
the proportion of patients with indwelling catheter
|
January 2015 to December 2017
|
pyuria rate
Time Frame: January 2015 to December 2017
|
the proportion of patients with pyuria
|
January 2015 to December 2017
|
Candiduria rate
Time Frame: January 2015 to December 2017
|
the proportion of patients with Candiduria
|
January 2015 to December 2017
|
treatment rate
Time Frame: January 2015 to December 2017
|
the proportion of patients with Candiduria treated with antifungal agents
|
January 2015 to December 2017
|
mortality rate
Time Frame: January 2015 to December 2017
|
|
January 2015 to December 2017
|
average indwelling catheter duration
Time Frame: January 2015 to December 2017
|
The sum of indwelling catheter durations / the number of all hospitalized patients with Candiduria
|
January 2015 to December 2017
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2019
Primary Completion (Actual)
July 31, 2020
Study Completion (Actual)
September 16, 2020
Study Registration Dates
First Submitted
April 7, 2019
First Submitted That Met QC Criteria
April 9, 2019
First Posted (Actual)
April 10, 2019
Study Record Updates
Last Update Posted (Actual)
October 8, 2020
Last Update Submitted That Met QC Criteria
October 5, 2020
Last Verified
October 1, 2020
More Information
Terms related to this study
Other Study ID Numbers
- CE18273B
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on no intervention
-
Wave NeuroscienceCompletedAutistic DisorderUnited States
-
University of Alabama at BirminghamCompletedInflammatory Bowel Diseases | Colorectal Cancer | Diverticular Diseases | Social BehaviorUnited States
-
Janssen Research & Development, LLCCompletedLupus Erythematosus, Systemic | Lupus Erythematosus, Cutaneous | Lupus Erythematosus, DiscoidUnited States, Poland
-
Hospital Universitario La Paz3MVX CCB and Agaplesion Markus Krankenhaus, Frankfurt a.M., Germany.; Department...RecruitingEmbolism | Atrial Fibrillation | Arrhythmia | Stroke, Acute | Stroke Sequelae | AblationSpain
-
Southern California College of Optometry at Marshall...Ohio State University; University of Houston; Alcon Research; University of Waterloo and other collaboratorsCompletedContact Lens Complication | Contact Lens Acute Red Eye | Contact Lens Related Corneal Infiltrate (Disorder) | Contact Lens-Induced Corneal Fluorescein StainingUnited States, Canada
-
University of Dublin, Trinity CollegeCompleted
-
Hôpital Necker-Enfants MaladesUnknown
-
China Medical University HospitalUnknownIntention to Stay, Turnover Behavior
-
Medical Corps, Israel Defense ForceUnknownMusculoskeletal Disorders | Upper Extremity Pain ChronicIsrael